Valeo Medical Inc.
This article was originally published in Start Up
The founders of Valeo Medical believe that endometriosis, a leading cause of infertility in the US, is a type of auto-immune disorder. Based on this premise, Valeo is developing an endometriosis diagnostic by searching for auto-antibodies to a variety of carbohydrate antigens in serum samples. The company believes the market opportunity is great, because there is no non-invasive diagnostic for endometriosis.
You may also be interested in...
Women's health is an area long shunned by pharmaceutical and diagnostic companies. But that is starting to change thanks to the successes of companies such as Cytyc and Digene, who have built successful testing franchises in the Ob/ Gyn market. As companies such as PerkinElmer and others look to develop new tests in this market, a spate of start-ups are developing technologies that might fit the bill. Of greatest interest are the so-called molecular tests since they offer the advantage of premium pricing.
The US FDA released five device-related close-out letters in March.